Chrystalla Antoniou1, Jonathon Hull2. 1. Faculty of Health and Life Sciences, University of the West of England, Coldharbour Lane, Bristol, BS16 1QY, UK. 2. Faculty of Health and Life Sciences, University of the West of England, Coldharbour Lane, Bristol, BS16 1QY, UK. jonathon2.hull@uwe.ac.uk.
Abstract
PURPOSE OF REVIEW: The olive tree (Olea europaea L.) has featured as a significant part of medicinal history, used to treat a variety of ailments within folk medicine. The Mediterranean diet, which is rich in olive products, is testament to Olea europaeas positive effects on health, associated with reduced incidences of cancer and cardiovascular disease. This review aims to summarise the current literature regarding the therapeutic potential of Olea europaea products in cancer, detailing the possible compounds responsible for its chemotherapeutic effects. RECENT FINDINGS: Much of the existing research has focused on the use of cell culture models of disease, demonstrating Olea europaea extracts, and specific compounds within these extracts, have efficacy in a range of in vitro and in vivo cancer models. The source of Olea europaeas cytotoxicity is yet to be fully defined; however, compounds such as oleuropein and verbascoside have independent cytotoxic effects on animal models of cancer. Initial results from animal models are promising but need to be translated to a clinical setting. Treatments utilising these compounds are likely to be well tolerated and represent a promising direction for future research.
PURPOSE OF REVIEW: The olive tree (Olea europaea L.) has featured as a significant part of medicinal history, used to treat a variety of ailments within folk medicine. The Mediterranean diet, which is rich in olive products, is testament to Olea europaeas positive effects on health, associated with reduced incidences of cancer and cardiovascular disease. This review aims to summarise the current literature regarding the therapeutic potential of Olea europaea products in cancer, detailing the possible compounds responsible for its chemotherapeutic effects. RECENT FINDINGS: Much of the existing research has focused on the use of cell culture models of disease, demonstrating Olea europaea extracts, and specific compounds within these extracts, have efficacy in a range of in vitro and in vivo cancer models. The source of Olea europaeas cytotoxicity is yet to be fully defined; however, compounds such as oleuropein and verbascoside have independent cytotoxic effects on animal models of cancer. Initial results from animal models are promising but need to be translated to a clinical setting. Treatments utilising these compounds are likely to be well tolerated and represent a promising direction for future research.
Authors: Attilio Giacosa; Roberto Barale; Luigi Bavaresco; Piers Gatenby; Vincenzo Gerbi; Jaak Janssens; Belinda Johnston; Koen Kas; Carlo La Vecchia; Paul Mainguet; Paolo Morazzoni; Eva Negri; Claudio Pelucchi; Mario Pezzotti; Mariangela Rondanelli Journal: Eur J Cancer Prev Date: 2013-01 Impact factor: 2.497
Authors: Ramón Estruch; Emilio Ros; Jordi Salas-Salvadó; Maria-Isabel Covas; Dolores Corella; Fernando Arós; Enrique Gómez-Gracia; Valentina Ruiz-Gutiérrez; Miquel Fiol; José Lapetra; Rosa Maria Lamuela-Raventos; Lluís Serra-Majem; Xavier Pintó; Josep Basora; Miguel Angel Muñoz; José V Sorlí; José Alfredo Martínez; Miguel Angel Martínez-González Journal: N Engl J Med Date: 2013-02-25 Impact factor: 91.245
Authors: Shaoping Fu; David Arráez-Roman; Antonio Segura-Carretero; Javier A Menéndez; María P Menéndez-Gutiérrez; Vicente Micol; Alberto Fernández-Gutiérrez Journal: Anal Bioanal Chem Date: 2010-03-19 Impact factor: 4.142
Authors: Chloe D Goldsmith; Quan V Vuong; Elham Sadeqzadeh; Costas E Stathopoulos; Paul D Roach; Christopher J Scarlett Journal: Molecules Date: 2015-07-17 Impact factor: 4.411
Authors: Hanen Sellami; Shakeel Ahmad Khan; Ishaq Ahmad; Abdullah A Alarfaj; Abdurahman H Hirad; Ahmed E Al-Sabri Journal: Int J Mol Sci Date: 2021-11-22 Impact factor: 5.923